Skip to Main Content

Paper Details

Adverse drug event rates in pediatric pulmonary hypertension: a comparison of real-world data sources.
J Am Med Inform Assoc
10
2020
ADE, ADEs, children, hearing loss, patients, pediatric pulmonary hypertension, pulmonary hypertension
Author NameAffiliation
Alon GevaBoston Children's Hospital
Alon GevaHarvard Medical School
Alon GevaBoston Children's Hospital
Alon GevaBoston Children's Hospital
Alon GevaBoston Children's Hospital
Alon GevaHarvard Medical School
Steven H AbmanChildren's Hospital Colorado
Steven H AbmanUniversity of Colorado School of Medicine
Shannon ManziBoston Children's Hospital
Shannon ManziClinical Pharmacogenomics Service, Department of Pharmacy, Boston Children's Hospital
Shannon ManziHarvard Medical School
Dunbar IvyUniversity of Colorado School of Medicine
Dunbar IvyHeart Institute, Children's Hospital Colorado
Mary P MullenHarvard Medical School
Mary P MullenBoston Children's Hospital
Guergana SavovaBoston Children's Hospital
Guergana SavovaHarvard Medical School
Kenneth D MandlBoston Children's Hospital
Kenneth D MandlHarvard Medical School
Kenneth D MandlHarvard Medical School
Kenneth D MandlBoston Children's Hospital
Kenneth D MandlHarvard Medical School
Kenneth D MandlHarvard Medical School
  • 1 - 23

Datasets